Experimental studies defining ω-3 fatty acid antiinflammatory mechanisms and abrogation of tumor-related syndromes

Nutrition in Clinical Practice

Volumn 20, Issue 1, 2005, Pages 62-74

  Babcock, Tricia A ^a   Bekoj, Thomas ^a   Espat, N Joseph ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; FISH OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; OMEGA 3 FATTY ACID; PROTEASOME; PROTEIN KINASE B; ROFECOXIB; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CACHEXIA; DIET SUPPLEMENTATION; HUMAN; IN VIVO CULTURE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; REVIEW; SEPSIS; TUMOR VOLUME; WESTERN BLOTTING;

EID: 13844312630     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/011542650502000162     Document Type: Review

References (66)

1. Siscovick DS, Raghunathan T, King I, et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr. 2000;71(suppl):208S-212S.
2. Barber MD, Ross JA, Preston T, Shenkin A, Fearon KC. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr. 1999;129:1120-1125.
3. De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J Parenter Enteral Nutr. 2003;27:52-57.
4. Booyens J, van der Merwe CF, Katzeff IE. Chronic arachidonic acid eicosanoid imbalance: a common feature in coronary artery disease, hypercholesterolemia, cancer and other important diseases: significance of desaturase enzyme inhibition and of the arachidonic acid desaturase-independent pathway. Med Hypotheses. 1985;18:53-60.
5. Kremer JM, Robinson DR. Studies of dietary supplementation with omega-3 fatty acids in patients with rheumatoid arthritis. World Rev Nutr Diet. 1991;66:367-382.
6. Sinclair H. Deficiency of essential fatty acids in atherosclerosis, etcetera. Lancet. 1956;1:381-383.
7. Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr. 1975;28:958-966.
8. Espat NJ, Moldawer LL, Copeland EM. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer-patients. J Surg Oncol. 1995;58:77-82.
9. Vane JR, Mitchell JA, Appleton I, et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A. 1994;91:2046-2050.
10. Herschman HR, Xie W, Reddy S. Inflammation, reproduction, cancer and all that: the regulation and role of the inducible prostaglandin synthase. Bioessays. 1995;17:1031-1037.
11. Dennis EA, Rhee SG, Billah MM, Hannun YA. Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J. 1991;5:2068-2077.
12. Mack SV, Mackrell PJ, Concannon EM, et al. NS-398 treatment after trauma modifies NF-kappaB activation and improves survival. J Surg Res. 2001;98:40-46.
13. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993;330:156-160.
14. Feuerstein G, Hallenbeck JM. Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol. 1987;27:301-313.
15. Schonbeck U, Sukhova GK, Graber P, Coulter S, Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol. 1999;155:1281-1291.
16. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 1993;268:9049-9054.
17. Hambleton J, Weinstein SL, Lem L, DeFranco AL. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci U S A. 1996;93:2774-2778.
18. Hwang D, Rhee SH. Receptor-mediated signaling pathways: potential targets of modulation by dietary fatty acids. Am J Clin Nutr. 1999;70:545-556.
19. Beutler B. Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol. 2000;3:23-28.
20. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol. 2000;12:20-26.
21. Lo CJ, Chiu KC, Fu M, Lo R, Helton S. Fish oil augments macrophage cyclooxygenase II (COX-2) gene expression induced by endotoxin. J Surg Res. 1999;86:103-107.
22. Lo CJ, Chiu KC, Fu M, Lo R, Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NFkappaB activity. J Surg Res. 1999;82:216-221.
23. Babcock TA, Helton WS, Hong D, Espat NJ. Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-alpha production. Surg Infect (Larchmt). 2002;3:145-149.
24. Babcock TA, Novak T, Ong E, Jho DH, Helton WS, Espat NJ. Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-alpha production by omega-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J Surg Res. 2002;107:135-139.
25. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA. 2003;100:1751-1756.
26. Babcock TA, Kurland A, Helton WS, Rahman A, Anwar KN, Espat NJ. Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. JPEN J Parenter Enteral Nutr. 2003;27:176-180.
27. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol. 2003;284:L84-L89.
28. Babcock TA, Helton WS, Anwar KN, Zhao Y, Espat NJ. Synergistic anti-inflammatory activity of omega-3 lipid and rofecoxib pre-treatment on macrophage pro-inflammatory cytokine production occurs via divergent NFkB activation. JPEN J Parenter Enteral Nutr. 2004;28:232-240.
29. Babcock TA, Helton WS, Espat NJ. Paradoxical IL-10 production by LPS-stimulated n-3 fatty acid and selective COX-2 inhibitor treated macrophages is associated with divergent P38 activation. Annual Meeting of Surgical Infection Society. Indianapolis, IN. 2004:P20.
30. Warren S. The immediate causes of death in cancer. Am J Med Sci. 1932;184:610-619.
31. Jho DH, Babcock TA, Tevar R, Helton WS, Espat NJ. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy. JPEN J Parenter Enteral Nutr. 2002;26:291-297.
32. Chen MK, Espat NJ, Bland KI, Copeland EM, Souba WW. Influence of progressive tumor-growth on glutamine-metabolism in skeletal-muscle and kidney. Ann Surg. 1993;217:655-667.
33. Dudrick PS, Inoue Y, Espat NJ, Souba WW. Na+-dependent glutamine transport in the liver of tumor-bearing rats. Surg Oncol Oxford. 1993;2:205-215.
34. Beck SA, Smith KL, Tisdale MJ. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res. 1991;51:6089-6093.
35. Lo CJ, Terasaki M, Garcia R, Helton S. Fish oil-supplemented feeding does not attenuate warm liver ischemia and reperfusion injury in the rat. J Surg Res. 1997;71:54-60.
36. Gabor H, Abraham S. Effect of dietary menhaden oil on tumor cell loss and the accumulation of mass of a transplantable mammary adenocarcinoma in BALB/c mice. J Natl Cancer Inst. 1986;76:1223-1229.
37. Hubbard NE, Erickson KL. Enhancement of metastasis from a transplantable mouse mammary tumor by dietary linoleic acid. Cancer Res. 1987;47:6171-6175.
38. Espat NJ, Copeland EM, Moldawer LL. Tumor-necrosis-factor and cachexia: a current perspective. Surg Oncol Oxford. 1994;3:255-262.
39. Rogy MA, Auffenberg T, Espat NJ, et al. Human tumor-necrosis-factor receptor (p55) and interleukin-10 gene-transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med. 1995;181:2289-2293.
40. Fischer E, Van Zee KJ, Marano MA, et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood. 1992;79:2196-2200.
41. Billiar TR, Bankey PE, Svingen BA, et al. Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery. 1988;104:343-349.
42. Lindros KO, Jokelainen K, Nanji AA. Acetaldehyde prevents nuclear factor-kappa B activation and hepatic inflammation in ethanol-fed rats. Lab Invest. 1999;79:799-806.
43. Tevar R, Jho DH, Babcock T, Helton WS, Espat NJ. omega-3 Fatty acid supplementation reduces tumor growth and vascular endothelial growth factor expression in a model of progressive non-metastasizing malignancy. JPEN J Parenter Enteral Nutr. 2002;26:285-289.
44. Rosenblatt S, Clowes GH Jr, George BC, Hirsch E, Lindberg B. Exchange of amino acids by muscle and liver in sepsis. Arch Surg. 1983;118:167-175.
45. Breen HB, Espat NJ. The ubiquitin proteasome proteolysis pathway; potential targets for disease intervention. JPEN J Parenter Enteral Nutr. 2004;28:272-278.
46. Mikhail AT, Babcock TA, Jho DH, Helton WS, Brodsky IG, Espat NJ. Modulation of the ubiquitin-proteasome proteolytic pathway by eicosapentaenoic acid supplementation in a model of progressive malignancy. JPEN J Parenter Enteral Nutr. 2003;27:105-109.
47. Tiao G, Fagan J, Roegner V, et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest. 1996;97:339-348.
48. Williams A, Sun XY, Fischer JE, Hasselgren PO. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surg. 1999;126:744-749.
49. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 1996;12:(suppl)S27-S30.
50. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998;82:395-402.
51. Mitch WE, Goldberg AL. Mechanisms of disease: mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway. N Engl J Med. 1996;335:1897-1905.
52. Baumeister W, Cejka Z, Kania M, Seemuller E. The proteasome: a macromolecular assembly designed to confine proteolysis to a nanocompartment. Biol Chem. 1997;378:121-130.
53. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Ann Rev Biochem. 1996;65:801-847.
54. Zwickl P, Grziwa A, Puhler G, Dahlmann B, Lottspeich F, Baumeister W. Primary structure of the Thermoplasma proteasome and its implications for the structure, function, and evolution of the multicatalytic proteinase. Biochemistry. 1992;31:964-972.
55. Gautier J, Pal JK, Desa MFG, Beetschen JC, Scherrer K. Differential cytolocalization of prosomes in axolotl during oogenesis and meiotic maturation. J Cell Sci. 1988;90:543-553.
56. Peters JM, Cejka Z, Harris JR, Kleinschmidt JA, Baumeister W. Structural features of the 26-S proteasome complex. J Mol Biol. 1993;234:932-937.
57. Baracos VE, DeVivo C, Hoyle DH, Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol. 1995;268:E996-E1006.
58. Hobler SC, Williams A, Fischer D, et al. Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis. Am J Physiol Regulat Integr Comp Physiol. 1999;277:R434-R440.
59. Whitehouse A, Smith H, Drake J. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res. 2001;61:3604-3609.
60. Wigmore SJ, Fearon KC, Maingay JP, Ross JA. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond). 1997;92:215-221.
61. Tisdale MJ. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition. 1996;12:S31-S33.
62. Blok WL, Vogels MT, Curfs JH, Eling WM, Buurman WA, Van der Meer JW. Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis. 1992;165:898-903.
63. Tisdale MJ, Beck SA. Inhibition of tumor-induced lipolysis in vitro and cachexia and tumor-growth in vivo by eicosapentaenoic acid. Biochem Pharmacol. 1991;41:103-107.
64. Grune T, Blasig IE, Sitte N, Roloff B, Haseloff R, Davies KJ. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem. 1998;273:10857-10862.
65. Ong ES, Babcock TA, Jho D, Holden C, Espat N. Leukocyte respiratory burst in tumor-bearing rats is independent of protein kinase B (Akt) inhibition by a selective COX-2 inhibitor. Ann Surg Oncol. 2003;10:S45.
66. Ong E, Kurland A, Jho D, Babcock TA, Espat N. n-3 Fatty acids but not COX-2 inhibitor treatment is anti-inflammatory in the lungs of tumor bearing rats independent of protein kinase B (Akt) activity. Ann Surg Oncol. 2004;11:S124.